| 000 | 01661 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518070031.0 | ||
| 264 | 0 | _c20201009 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1098-2299 | ||
| 024 | 7 |
_a10.1002/ddr.21606 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKattimani, Pramod P | |
| 245 | 0 | 0 |
_aNovel 5-(1-aryl-1H-pyrazol-3-yl)-1H-tetrazoles as glycogen phosphorylase inhibitors: An in vivo antihyperglycemic activity study. _h[electronic resource] |
| 260 |
_bDrug development research _c02 2020 |
||
| 300 |
_a70-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcrylonitrile _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aCycloaddition Reaction |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycogen Phosphorylase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aMolecular Dynamics Simulation |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStreptozocin |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTetrazoles _xadministration & dosage |
| 700 | 1 | _aSomagond, Shilpa M | |
| 700 | 1 | _aBayannavar, Praveen K | |
| 700 | 1 | _aKamble, Ravindra R | |
| 700 | 1 | _aBijjaragi, Subhas C | |
| 700 | 1 | _aHunnur, Raveendra K | |
| 700 | 1 | _aJoshi, Shrinivas D | |
| 773 | 0 |
_tDrug development research _gvol. 81 _gno. 1 _gp. 70-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ddr.21606 _zAvailable from publisher's website |
| 999 |
_c30282985 _d30282985 |
||